Medical Enzymes: Technologies and Global Markets

Report Highlights

The market for enzymes in medicine is growing. The global market for medical enzymes is estimated at $6 billion in 2010. The market is growing at a compound annual growth rate (CAGR) of 3.9%, to reach $7.2 billion in 2015.

Report Scope

The scope of this study encompasses medical or medicinal enzymes, bio-technical, pharmaceutical, and biotechnology markets.  BCC analyzes each market and its applications, regulatory environment, technology involved, market projections, and market share.  Technological issues include the latest trends and developments. 

Analyst Credentials

The study has been carried out by a team of professionals in the biotechnology industry.  The project manager for this project is Shalini S. Dewan, who holds a master’s degree in pharmaceutical chemistry and has more than 14 years of industry experience.  Among the research topics she has covered are studies on compounds of potential pharmaceutical interest from ibuprofen to 2-naphthyl acetic acid.  Ms. Dewan was awarded a gold medal by the prime minister of India for her work and has worked with top companies in India and in the U.S.  Some of her other reports with BCC are Reagents for Chromatography; Spectroscopy, an Enduring Market; Advanced Drug Delivery Systems: New Developments, New Technologies; Orthopedic Drugs, Implants and Devices; Medical Imaging Reagents; Pharmaceutical Regulatory Industry; The Dynamic Media, Sera and Reagent Market in Biotechnology; Contract Pharmaceutical Manufacturing, Research and Packaging; Chiral Technology: Global Markets; Autacoids and Related Drugs: Technologies and Global Markets; Contraceptives: Technologies and Global Markets; Liver Disease Treatments: The Global Market;  Hormone Replacement Therapies and Other Hormone Therapies: Global Markets; Cardiovascular Medicine: Diagnostics, Drugs and Devices; Cancer Therapies: Technologies and Global Markets; and Medical Imaging Reagents and Analysis Equipment.

The lead consultant for this project was Dr. Kapil A. Setia, who holds a doctoral degree in life sciences.  She has a number of research publications to her credit, including her thesis on Studies on Phenotypic Variation, Clonal Propagation and Phyto-chemistry of Tinospora cordifolia (Willd.), which was given an award of excellence.